GlobeImmune, Inc., a biopharmaceutical company, focuses on developing therapeutic products for cancer and infectious diseases based on proprietary Tarmogen platform. Its product candidate includes GS-4774, which is in Phase 2 trials for the treatment of patients with chronically infected with hepatitis B virus, as well as with oral antiviral suppressive therapy. The company is also involved in developing GI-6301 for the treatment of cancers expressing the brachyury protein; and GI-6207 that is in Phase 2 clinical trials to treat medullary thyroid cancer. In addition, it is involved in developing GI-4000, which is in Phase 2b clinical trials for the treatment of resected pancreas cancer; and is in Phase 2 clinical trial to treat non-small cell lung cancer, as well as is in Phase 2 clinical trial for the treatment of colorectal cancer. Further, the company is involved in developing various other product candidates targeting various infectious diseases that are in preclinical development stage, which include GI-19000 to treat tuberculosis; GI-2010 for the treatment of human immunodeficiency virus; and GI-18000 for hepatitis D virus infection. It has strategic collaborations with Gilead Sciences, Inc. and Celgene Corporation. The company was formerly known as Ceres Pharmaceuticals, Inc. and changed its name to GlobeImmune, Inc. in May 2001. GlobeImmune, Inc. was founded in 1995 and is headquartered in Louisville, Colorado. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of GlobeImmune, Inc..
GlobeImmune, Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of GlobeImmune, Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of GlobeImmune, Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of GlobeImmune, Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of GlobeImmune, Inc. and all latest updates of the company are provided.
The 2025 version of GlobeImmune, Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 GlobeImmune, Inc.- Key Facts
2.2 GlobeImmune, Inc.- Geographic Locations
2.3 GlobeImmune, Inc.- Subsidiaries and Affiliates
2.4 GlobeImmune, Inc.- Business Divisions
2.5 GlobeImmune, Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. GlobeImmune, Inc. Strategic Analysis Review
3.1 GlobeImmune, Inc.- Key Strategies
3.2 GlobeImmune, Inc.- Company Outlook Statement
3.3 GlobeImmune, Inc.- SWOT Analysis
3.3.1 GlobeImmune, Inc.- Key Strengths
3.3.2 GlobeImmune, Inc.- Key Weaknesses
3.3.3 GlobeImmune, Inc.- Potential Opportunities
3.3.4 GlobeImmune, Inc.- Potential Threats
3.4 GlobeImmune, Inc.- Key Competitors
4. Business Description of the Company
4.1 GlobeImmune, Inc.- Business Overview
4.2 GlobeImmune, Inc.- Operations by Segment
5 Products and Services Details
5.1 GlobeImmune, Inc.- Key Products
5.2 GlobeImmune, Inc.- Key Service Areas
5.3 GlobeImmune, Inc.- Key Brands
6 Company Developments
6.1 GlobeImmune, Inc.- Company History
6.2 GlobeImmune, Inc.- Latest Developments
7 Financial Analysis
7.1 GlobeImmune, Inc.- Income Statements
7.2 GlobeImmune, Inc.- Balance Sheet
7.3 GlobeImmune, Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 GlobeImmune, Inc.- Direct Competitors
8.2 GlobeImmune, Inc.- Competitor Financial Ratios comparison
8.3 GlobeImmune, Inc.- Competitor Stock Charts Comparison
8.4 GlobeImmune, Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!